Pharmaceutical / Drug Definition :
Competes with estrogen receptors in tumor cells for binding to target tissues (such as breast); reduces DNA synthesis and estrogen response
FDA Label Requirements and Exceptions
Tamoxifen Citrate
FDA Import Information
Tamoxifen Citrate
FDA Detentions
Tamoxifen Citrate (Tamoxifen Citrate Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Tamoxifen Citrate (Tamoxifen Citrate Suppliers)
- Processors Tamoxifen Citrate
- Repackers Tamoxifen Citrate
- Relabelers Tamoxifen Citrate
- Exporters Tamoxifen Citrate
- Importers Tamoxifen Citrate
For more information about Tamoxifen Citrate, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
